BCAS3 ELISA Kit
Kurzübersicht für BCAS3 ELISA Kit (ABIN6201894)
Target
Alle BCAS3 ProdukteReaktivität
Nachweismethode
Methodentyp
Detektionsbereich
Applikation
-
-
Untere Nachweisgrenze
- 0.313 ng/mL
-
Verwendungszweck
- Human Breast Carcinoma Amplified Sequence 3 (BCAS3) ELISA Kit is an ELISA kit against Breast Carcinoma Amplified Sequence 3 (BCAS3).
-
Analytische Methode
- Quantitative
-
Sensitivität
- < 0.19 ng/mL
-
-
-
Applikationshinweise
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
-
Plattentyp
- Pre-coated
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
-
Haltbarkeit
- 6 months
-
-
- BCAS3 (Breast Carcinoma Amplified Sequence 3 (BCAS3))
-
UniProt
- Q9H6U6
Target Alle BCAS3 Produkte
-